Tenax Therapeutics Stock (NASDAQ: TENX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 345.340K |
Day Range | - - - |
52 Wk Range | 3.480 - 61.200 |
Market Cap | $7.480M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 2.51% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Tenax Therapeutics (NASDAQ: TENX) through any online brokerage.
Other companies in Tenax Therapeutics’s space includes: Virios Therapeutics (NASDAQ:VIRI), Trevena (NASDAQ:TRVN), AquaBounty Techs (NASDAQ:AQB), Protagenic Therapeutics (NASDAQ:PTIX) and Lixte Biotechnology (NASDAQ:LIXT).
The latest price target for Tenax Therapeutics (NASDAQ: TENX) was reported by Roth MKM on Tuesday, February 20, 2024. The analyst firm set a price target for 30.00 expecting TENX to rise to within 12 months (a possible 685.34% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Tenax Therapeutics (NASDAQ: TENX) is $3.82 last updated April 17, 2024 at 7:49 PM EDT.
There are no upcoming dividends for Tenax Therapeutics.
Tenax Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Tenax Therapeutics.
Tenax Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.